The Pulmonary Vascular Research Institute

🚨 The wait is over — registration and abstract submissions are officially open for #PVRI2026 With the theme of Celebrating 20 Years of Progress & Innovation, join us in Dublin from 28 January – 1 February for world-class science, dynamic discussions, and impactful networking…

🚨 Women’s Health Task Force is back — and we want you to be part of it! Join us for a dedicated webinar on 9 September (3PM BST) to explore women’s health and pulmonary vascular disease, hear from experts, and help shape the Task Force’s direction: · Background and PHANTOM…

Catch up on Martin Wilkins’ presentation from #DDDS2025, where he explored the limitations of relying on single reading averages from traditional clinical trials and made the case for n-of-1 studies in PAH: 🔹 Valuable for assessing novel treatments in rare conditions like PAH…

📢Call for Abstracts Submit your research for #PVRI2026 by 1 October 2025 🗓️ We’re inviting abstracts across four exciting themes: 1. Basic & Translational Science 2. Clinical Science 3. International & Global Health 4. Mind the Gap: Cases that Highlight Gaps in Evidence Best…

🌍 Ready to take on a fitness challenge with global impact for pulmonary hypertension? Join #BreathBeyondBorders this November for #PHAwarenessMonth. PVRI members and friends around the world are invited to take on personal challenges — walking, running, cycling, yoga-ing, speed…

New publication: Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension by Clara Hjalmarsson Et al. Read the full research article 👉onlinelibrary.wiley.com/doi/10.1002/pu…

🎉 Our #PVRIDigital Webinar Series is back this September! Join us on the 2nd Thursday of each month at 16:00 BST/GMT for inspiring keynote talks from global PH experts — alternating between: 🔬 Cutting Edge Innovation in Clinical & Experimental PH 🎙️ Living Legends in PH:…

📢Big news for the PH community! Findings from the global PH GPS adult survey (3,300+ patients, 90 countries) are now published. PHAEUROPE’s Eva Otter & Gery Fischer are among co-authors. ⤵️ tinyurl.com/yjurrmhn

📢 New publication from our Paediatric Clinical Trial Design & Endpoints Workstream: Enhancing Drug Development for Paediatric Pulmonary Hypertension—An Integrative Perspective. Congrats Steven Abman, Sylvia Nikkho, Rolf Berger, Maria Jesus del Cerro, Eric Austin, Maurice…

📢 NEW Webinar: Paediatric Bridge to Transplant 📅 29 July 2025, 16:00 BST Our Lung Transplantation in Pulmonary Hypertension Workstream will be presenting a webinar on expert strategies for bridging paediatric patients to lung transplant. Expert speakers & moderators include:…

📢 Good news! 📢Our #PHGPS, the largest global survey exploring the perspectives of #PulmonaryHypertension patients, has identified 10 key global priorities for improving #PulmonaryHypertension care in adult patients. These 10 calls to action aim to enhance equitable access to…

How to define or prove disease modification - catch up on @mark_toshner's thought-provoking talk from #DDDS2025 as he explores: 🔹 Regulators definition of disease modification 🔹 Biomarkers of disease activity 🔹 Can we use high dimension ‘feel & function’ data to define…

Thanks to the collaborative efforts of @CRC1213 New in Nature Cardiovascular Research: We uncover molecular signaling of reversible ECM and cytoskeletal remodeling in the RV of CTEPH patients before and after PEA surgery🫀 @PVRI @AHAScience @3CPRCouncil nature.com/articles/s4416…

📢 New publication: Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry by Arun Jose, Athiththan Yogeswaran, Khodr Tello, @ElwingJean, Werner Seeger, Meike Fünderich Et al. Read the full research article…

Registration & abstract submissions for #PVRI2026 are now open! Join us in Dublin for world-class science, global collaboration, and exciting satellite meetings. 📢 Submit your abstract 🎟️ Secure your place 🔗 pvrinstitute.org/pvri2026 #PulmonaryHypertension #CallForAbstracts…

Great news! Key findings just published in the ERJ Open Research from our Pulmonary Hypertension Global Patient Survey #PHGPS adult cohort of 3,329 patients highlight the achievements, shortcomings & regional disparities of #PH clinical care & research globally. Findings in the…

How to use imaging endpoints reflecting the pulmonary circulation & RV - catch up on David Kiely's insightful talk from #DDDS2025 as he explores: 🔹 Why do we need to consider using an imaging end-point in PH trials? 🔹 What imaging can we use to assess the cardiopulmonary…

Missed it? Catch up on @DrRahulKumarPhD presentation on the role of inflammatory immune cells in hypoxic pulmonary hypertension. 🎥 Now available to watch on demand — free to access: pvrinstitute.org/learning-hub/m… #HighAltitude #Hypoxia #PulmonaryHypertension #Webinar